Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Inflammatory Bowel Diseases

  Free Subscription

Articles published in J Gastroenterol

Retrieve available abstracts of 25 articles:
HTML format

Single Articles

    November 2022
  1. ANDOH A, Nishida A
    Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease.
    J Gastroenterol. 2022 Nov 14. pii: 10.1007/s00535-022-01936.
    PubMed     Abstract available

  2. MATSUOKA K, Fujii T, Okamoto R, Yamada A, et al
    Characteristics of adult patients newly diagnosed with Crohn's disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn's disease in Japan (iCREST-CD).
    J Gastroenterol. 2022;57:867-878.
    PubMed     Abstract available

    October 2022
  3. YAMAWAKA T, Kitamoto H, Nojima M, Kazama T, et al
    The association between antigenemia, histology with immunohistochemistry, and mucosal PCR in the diagnosis of ulcerative colitis with concomitant human cytomegalovirus infection.
    J Gastroenterol. 2022 Oct 26. pii: 10.1007/s00535-022-01931.
    PubMed     Abstract available

  4. OHARA J, Nemoto T, Maeda Y, Ogata N, et al
    Deep learning-based automated quantification of goblet cell mucus using histological images as a predictor of clinical relapse of ulcerative colitis with endoscopic remission.
    J Gastroenterol. 2022 Oct 3. pii: 10.1007/s00535-022-01924.
    PubMed     Abstract available

  5. NOGUCHI T, Ishihara S, Uchino M, Ikeuchi H, et al
    Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn's disease.
    J Gastroenterol. 2022 Oct 2. pii: 10.1007/s00535-022-01927.
    PubMed     Abstract available

  6. WANG Z, Iida N, Seishima J, Okafuji H, et al
    Patient-derived Enterococcus faecium with inflammatory genotypes promote colitis.
    J Gastroenterol. 2022;57:770-783.
    PubMed     Abstract available

    August 2022
  7. IMAI T, Inoue R, Nishida A, Yokota Y, et al
    Features of the gut prokaryotic virome of Japanese patients with Crohn's disease.
    J Gastroenterol. 2022;57:559-570.
    PubMed     Abstract available

    July 2022
  8. JORDI SBU, Lang BM, Wyss J, Auschra B, et al
    The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients.
    J Gastroenterol. 2022 Jul 28. pii: 10.1007/s00535-022-01902.
    PubMed     Abstract available

  9. VAN HOEVE K, Hoffman I
    Renal manifestations in inflammatory bowel disease: a systematic review.
    J Gastroenterol. 2022 Jul 14. pii: 10.1007/s00535-022-01903.
    PubMed     Abstract available

  10. ALLIN KH, Jensen CB, Jacobsen RK, Jess T, et al
    Metformin use is not associated with reduced risk of older onset inflammatory bowel disease: a Danish nationwide population-based study.
    J Gastroenterol. 2022 Jul 2. pii: 10.1007/s00535-022-01896.
    PubMed     Abstract available

    March 2022
  11. KISHI M, Hirai F, Takatsu N, Hisabe T, et al
    A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation.
    J Gastroenterol. 2022 Mar 2. pii: 10.1007/s00535-022-01862.
    PubMed     Abstract available

    February 2022
  12. SHIMIZU H, Ebana R, Kudo T, Sato T, et al
    Both fecal calprotectin and fecal immunochemical tests are useful in children with inflammatory bowel disease.
    J Gastroenterol. 2022 Feb 14. pii: 10.1007/s00535-022-01856.
    PubMed     Abstract available

    January 2022
  13. NAKASE H, Hayashi Y, Hirayama D, Matsumoto T, et al
    Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS).
    J Gastroenterol. 2022 Jan 28. pii: 10.1007/s00535-022-01851.
    PubMed     Abstract available

  14. MIYOSHI J, Ozaki R, Yonezawa H, Mori H, et al
    Ratio of submucosal thickness to total bowel wall thickness as a new sonographic parameter to estimate endoscopic remission of ulcerative colitis.
    J Gastroenterol. 2022 Jan 24. pii: 10.1007/s00535-021-01847.
    PubMed     Abstract available

    October 2021
  15. ANDO K, Fujiya M, Watanabe K, Hiraoka S, et al
    A nationwide survey concerning the mortality and risk of progressing severity due to arterial and venous thromboembolism in inflammatory bowel disease in Japan.
    J Gastroenterol. 2021 Oct 5. pii: 10.1007/s00535-021-01829.
    PubMed     Abstract available

    September 2021
  16. MIURA M, Shimizu H, Saito D, Miyoshi J, et al
    Multicenter, cross-sectional, observational study on Epstein-Barr viral infection status and thiopurine use by age group in patients with inflammatory bowel disease in Japan (EBISU study).
    J Gastroenterol. 2021 Sep 30. pii: 10.1007/s00535-021-01832.
    PubMed     Abstract available

  17. TOYONAGA T, Kobayashi T, Kuronuma S, Ueno A, et al
    Increased DNA-incorporated thiopurine metabolite as a possible mechanism for leukocytopenia through cell apoptosis in inflammatory bowel disease patients with NUDT15 mutation.
    J Gastroenterol. 2021 Sep 4. pii: 10.1007/s00535-021-01820.
    PubMed     Abstract available

    August 2021
  18. NISHIOKA K, Ogino H, Chinen T, Ihara E, et al
    Mucosal IL23A expression predicts the response to Ustekinumab in inflammatory bowel disease.
    J Gastroenterol. 2021 Aug 27. pii: 10.1007/s00535-021-01819.
    PubMed     Abstract available

    July 2021
  19. MATSUOKA K, Ishikawa H, Nakayama T, Honzawa Y, et al
    Physician-patient communication affects patient satisfaction in treatment decision-making: a structural equation modelling analysis of a web-based survey in patients with ulcerative colitis.
    J Gastroenterol. 2021 Jul 27. pii: 10.1007/s00535-021-01811.
    PubMed     Abstract available

  20. ANDOH A, Kawahara M, Imai T, Tatsumi G, et al
    Thiopurine pharmacogenomics and pregnancy in inflammatory bowel disease.
    J Gastroenterol. 2021 Jul 21. pii: 10.1007/s00535-021-01805.
    PubMed     Abstract available

    May 2021
  21. SHINZAKI S, Matsuoka K, Tanaka H, Takeshima F, et al
    Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study.
    J Gastroenterol. 2021 May 3. pii: 10.1007/s00535-021-01793.
    PubMed     Abstract available

    April 2021
  22. NAKASE H, Uchino M, Shinzaki S, Matsuura M, et al
    Evidence-based clinical practice guidelines for inflammatory bowel disease 2020.
    J Gastroenterol. 2021 Apr 22. pii: 10.1007/s00535-021-01784.
    PubMed     Abstract available

    January 2021
  23. TAKABAYASHI K, Hosoe N, Kato M, Hayashi Y, et al
    Significance of endoscopic deep small bowel evaluation using balloon-assisted enteroscopy for Crohn's disease in clinical remission.
    J Gastroenterol. 2021;56:25-33.
    PubMed     Abstract available

    November 2020
  24. KOHYAMA A, Watanabe K, Sugita A, Futami K, et al
    Ulcerative colitis-related severe enteritis: an infrequent but serious complication after colectomy.
    J Gastroenterol. 2020 Nov 5. pii: 10.1007/s00535-020-01742.
    PubMed     Abstract available

  25. KITA T, Ashizuka S, Ohmiya N, Yamamoto T, et al
    Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trial.
    J Gastroenterol. 2020 Nov 2. pii: 10.1007/s00535-020-01741.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.